Case Report: Olaparib Shows Satisfactory Clinical Outcomes Against Small Cell Esophageal Carcinoma With ATM Mutation

Case Report: Olaparib Shows Satisfactory Clinical Outcomes Against Small Cell Esophageal Carcinoma With ATM Mutation

Small cell esophageal carcinoma (SCEC) is a rare, undifferential type of cancer, with a high degree of malignancy and early systemic metastasis. Radio-chemotherapy and surgery have been used as the primary treatment strategies for SCEC, but they both result in poor prognosis. There is need to develo...

Full description

Bibliographic Details
Main Authors: Weiwei Wang, Xiaoyan Zhang, Yu Fang, Jia He, Jingjing Huang, Shanqing Li, Tonghui Ma, Li Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
case report
olaparib
SCEC
ATM mutation
PARP inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.808801/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.808801/full

Similar Items